Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial
Month 1: 0.5 mg, once daily Month 2: 1 mg, once daily Month 3: 1.5 mg, once daily Month 4: 2 mg, once daily Month 5 and beyond (maintenance): 2.5 mg, once daily Medication is prescribed only after consultation with a licensed provider to determine appropriateness
Liu J, Head E, Kuratsune H, Cotman CW, Ames BN
PubMed laboratory research record [PMID: 16227137] PubMed record related to this compound for laboratory literature review
7ad), even though it promoted the accumulation of GSH in cells (Extended Data Fig
Results require patience, as hair growth cycles span months